logo
Gold Coast penthouse sets record with $19.57 million sale

Gold Coast penthouse sets record with $19.57 million sale

7NEWS30-07-2025
The Gold Coast's luxury apartment market has notched another record with the $19,568,000 sale of a full-floor penthouse in the Royale Gold Coast development-just weeks after the project set a previous benchmark with a $19.18 million penthouse sale.
Together, the two penthouse deals have generated over $38 million in off-the-plan sales, marking the highest transactions of their kind in Surfers Paradise history and reinforcing the city's newfound prestige in the national property market.
The latest deal, for Penthouse 3601 on level 36, was secured by a local businessman who had originally purchased a half-floor residence in the building, only to upgrade when the full-floor penthouse was released to market. As the tower's form has become more prominent during construction, the buyer was drawn by the opportunity to secure an expansive, uninterrupted coastal view from a residence unlike anything else in the region.
" Royale Gold Coast is unlike any other project in the Australian market," said David Devine, founder and managing director of DD Living.
"Its sculptural form, premium north-east orientation and floor-to-ceiling glass have been meticulously designed to maximise natural light and capture uninterrupted 360-degree views across the ocean, hinterland and city skyline."
Each penthouse offers over 660 square metres of indoor and outdoor space, with features including a gourmet kitchen fitted with Wolf and Sub-Zero appliances, an oversized butler's pantry, glass-enclosed wine cellar, full-sized bar, formal dining for 14, and expansive indoor-outdoor entertaining zones. The master suite occupies the entire eastern wing and includes a resort-style ensuite with a freestanding bath, double showers and floor-to-ceiling glass offering uninterrupted ocean vistas.
Residents of Royale will also enjoy six-star resort-style amenities such as two lagoon pools, a wellness centre with spa, cold plunge, sauna and yoga terrace, as well as the private Club Royale residents' lounge with an executive kitchen and beachfront views.
According to luxury apartment specialist Adrian Parsons, Managing Director of TOTAL Property Group, the Gold Coast's prestige apartment sector is being fuelled by both demand and a significant shift in who's buying.
"Many of the purchasers in the luxury apartment market are local Gold Coast owner-occupiers intending to live in the residences full-time," Parsons said.
"We're also seeing strong demand from Brisbane and interstate buyers. While some are securing apartments as premium holiday homes, a significant proportion are planning a permanent move to the Gold Coast to enjoy the lifestyle on offer year-round."
Parsons attributes the current boom to the city's broader transformation into a diversified economic hub.
"The Gold Coast has matured significantly in recent years, evolving into a more resilient economy that is no longer solely reliant on tourism," he said. "This transformation has supported continued interstate migration, with more people choosing to make the Gold Coast their permanent home. The region's lifestyle, climate, and world-class amenities continue to attract high-end apartment buyers seeking both luxury and liveability."
With absolute beachfront development sites now scarce, Parsons also noted that developers are turning their attention to emerging lifestyle markets across Southeast Queensland. "These areas offer strong long-term growth potential and are gaining attention from both developers and discerning buyers alike," he said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines
‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Sydney Morning Herald

time25 minutes ago

  • Sydney Morning Herald

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Health Minister Mark Butler is planning to speed up medicines approvals as United States President Donald Trump threatens to put tariffs of up to 250 per cent on pharmaceutical products, which could affect $2 billion worth of Australian exports. Butler said Trump's latest threat would not change the discount Australians received on medicines through the Pharmaceutical Benefits Scheme, but revealed he would get advice within days about accelerating the approvals process for new drugs in Australia – a key issue that US pharmaceutical giants have raised with Trump. Speeding up the timeframe for US medicines to land on pharmacy shelves could improve the Australian government's standing with the Trump administration, although it does not deal with the White House's bigger concern that Americans pay more for medicines than citizens of other countries. Trump's anger with what he called 'foreign freeloading nations' prompted him to threaten tariffs of up to 250 per cent on drug imports this week. Butler said it was a 'a very big threat'. 'It's one we're working very hard to engage with the Americans on,' Butler said on Thursday. Loading 'The numbers are jumping around … They were 200 per cent a couple of weeks ago, and now they're 250 per cent potentially. They are very, very big tariffs. 'We are making the case very strongly, but I'm not going to pretend that the US Administration doesn't appear to be pretty serious about this.' Australia's PBS – under which the government subsidises drugs and Australians can buy expensive medicines for a maximum price of $31.60, soon to become $25 – has been brought up repeatedly during Trump's trade wars as US pharmaceutical companies push the president to punish countries that limit their market access.

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines
‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

The Age

time25 minutes ago

  • The Age

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Health Minister Mark Butler is planning to speed up medicines approvals as United States President Donald Trump threatens to put tariffs of up to 250 per cent on pharmaceutical products, which could affect $2 billion worth of Australian exports. Butler said Trump's latest threat would not change the discount Australians received on medicines through the Pharmaceutical Benefits Scheme, but revealed he would get advice within days about accelerating the approvals process for new drugs in Australia – a key issue that US pharmaceutical giants have raised with Trump. Speeding up the timeframe for US medicines to land on pharmacy shelves could improve the Australian government's standing with the Trump administration, although it does not deal with the White House's bigger concern that Americans pay more for medicines than citizens of other countries. Trump's anger with what he called 'foreign freeloading nations' prompted him to threaten tariffs of up to 250 per cent on drug imports this week. Butler said it was a 'a very big threat'. 'It's one we're working very hard to engage with the Americans on,' Butler said on Thursday. Loading 'The numbers are jumping around … They were 200 per cent a couple of weeks ago, and now they're 250 per cent potentially. They are very, very big tariffs. 'We are making the case very strongly, but I'm not going to pretend that the US Administration doesn't appear to be pretty serious about this.' Australia's PBS – under which the government subsidises drugs and Australians can buy expensive medicines for a maximum price of $31.60, soon to become $25 – has been brought up repeatedly during Trump's trade wars as US pharmaceutical companies push the president to punish countries that limit their market access.

Gilbert + Tobin M&A heavyweight Tim Gordon defects to rival law firm Corrs Chambers Westgarth
Gilbert + Tobin M&A heavyweight Tim Gordon defects to rival law firm Corrs Chambers Westgarth

AU Financial Review

time25 minutes ago

  • AU Financial Review

Gilbert + Tobin M&A heavyweight Tim Gordon defects to rival law firm Corrs Chambers Westgarth

Gilbert + Tobin co-founder and chairman Danny Gilbert has lost his protege, nurtured over the past 11 years. Tim Gordon was made an executive partner in June 2023. Firms are performing strongly, thanks to demand for advice around corporate disputes, energy transition and infrastructure deals. The founding partner of King & Wood was certainly busy shoring up his Australian interests in 2012. See all Gilbert & Tobin news

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store